Is Genetic Technologies Limited (GNTLF) a Buy, Sell, or Hold?
OTC : GNTLF
Genetic Technologies Limited
$1 USD
$0 (0.0%)
- Volume
- 100
- Average Volume
- 89
- Market Capitalization
- $1.34B
- P/E Ratio
- -0.43
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.00
- Year Low
- $1.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.88
Company Overview
OTC
Kevin Camilleri
Medical - Diagnostics & Research
Healthcare
GNTLF
55
AU
USD
Liquidity Metrics
0.48
0.88
0.83
0.24
0.00
Sales & Valuation
$9.67M
0.74
2.95
-0.58
-0.07
Profitability
-$0.0909
-$12.02M
-156.78%
-156.78%
-184.98%
-194.25%
P/E Metrics
-0.43
0.00
0.00
Analyst Price Target & Rating
0/5
1 Analysts
%
Financial Health Scores
134.12
3/9
-$2.17M
$1.75M
$3.92M
-$15.44M
Key Metrics (TTM)
$5.53M
0.72
-0.48
0.88
-184.98%
-429.43%
-222.69%
-171.25%
-20 days
Company Executives
| Name | Title |
|---|---|
| Michael Walker | Executive Chairman & MD |
| Paul Keith Mathieson Viney FCPA FGIA | Consultant |
| Erika Spaeth | Director of Clinical & Scientific Affairs |
| Priyamvada Sanjay Rasal | Company Secretary |
| Kevin Camilleri | Chief Executive Officer of EasyDNA |
Poll Results
No votes yet today — be the first to share your view!
About Genetic Technologies Limited (OTC:GNTLF) Stock
Genetic Technologies Limited, trading as GNTLF, is an Australian molecular diagnostics enterprise dedicated to creating and delivering advanced predictive assessment instruments. These tools are designed to assist medical professionals in Australia and the United States with managing women's health. The company's primary offering is BREVAGenplus, a meticulously validated risk evaluation test specifically for non-inherited breast cancer. Genetic Technologies promotes BREVAGenplus to a wide array of healthcare specialists, including those working in breast health clinics and imaging centers, obstetricians/gynecologists, and experts in breast cancer risk analysis, such as breast surgeons. Beyond this flagship product, the firm provides additional cancer risk assessment tests under the GeneTyp ... e brand, specifically for Colorectal Cancer and Breast Cancer. It also has ongoing development efforts for new risk assessment diagnostics targeting various conditions, including cardiovascular disease, type 2 diabetes, prostate cancer, and melanoma. Furthermore, the company offers a comprehensive suite of genetic testing services encompassing medical, animal, forensic, and botanical applications. Established in 1987 and headquartered in Fitzroy, Australia, Genetic Technologies Limited actively engages in research and collaborative ventures with prominent institutions such as the University of Melbourne, the Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom.
Frequently Asked Questions
-
What is the current Genetic Technologies Limited (GNTLF) stock price?
-
Genetic Technologies Limited(OTC:GNTLF) stock price is $1 in the last trading session. During the trading session, GNTLF stock reached the peak price of $1 while $1 was the lowest point it dropped to. The percentage change in GNTLF stock occurred in the recent session was 0.0% while the dollar amount for the price change in GNTLF stock was $0.
-
GNTLF's industry and sector of operation?
-
The OTC listed GNTLF is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of GNTLF?
-
Michael Walker | Executive Chairman & MD
Paul Keith Mathieson Viney FCPA FGIA | Consultant
Erika Spaeth | Director of Clinical & Scientific Affairs
Priyamvada Sanjay Rasal | Company Secretary
Kevin Camilleri | Chief Executive Officer of EasyDNA -
How many employees does GNTLF have?
-
Number of GNTLF employees currently stands at 55. GNTLF operates from 60-66 Hanover Street, Maroochydore, QL 3065, AU.
-
Link for GNTLF official website?
-
Official Website of GNTLF is: https://genetype.com
-
How do I contact GNTLF?
-
GNTLF could be contacted at phone #61 3 8412 7000 and can also be accessed through its website. GNTLF operates from 60-66 Hanover Street, Maroochydore, QL 3065, AU.
-
How many shares of GNTLF are traded daily?
-
The average number of GNTLF shares traded daily for last 3 months was 89.
-
What is the market cap of GNTLF currently?
-
The market value of GNTLF currently stands at $1.34B with its latest stock price at $1